Cargando…
Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer
BACKGROUND: There is growing evidence that the transcription factor nuclear factor E2-related factor 2 (Nrf2) is the major participant in regulating antioxidants and pathways for detoxifying reactive oxygen species (ROS), as well as having a vital role in tumor proliferation, invasion, and chemoresi...
Autores principales: | Nukui, Akinori, Narimatsu, Takahiro, Kambara, Tsunehito, Abe, Hideyuki, Sakamoto, Setsu, Yoshida, Ken-Ichiro, Kamai, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930508/ https://www.ncbi.nlm.nih.gov/pubmed/29716554 http://dx.doi.org/10.1186/s12885-018-4427-1 |
Ejemplares similares
-
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
por: Nukui, Akinori, et al.
Publicado: (2020) -
Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis
por: Yuki, Hideo, et al.
Publicado: (2018) -
Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
por: Mizuno, Tomoya, et al.
Publicado: (2015) -
Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival
por: Kamai, Takao, et al.
Publicado: (2021) -
5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase
por: Narimatsu, Takahiro, et al.
Publicado: (2019)